PC1 header corporate Ads

PC1 header corporate Ads

X

Company profile for Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

ALNYLAM PHARMACEUTICALS

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation

Corporate Presentation

VIDEO(s)

No Video

DIGITAL CONTENT

228 News

228 News

DEVELOPMENTS

66 Drug(s) in Development

66 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

4 Dossiers, 4 FDA Orange Book

Contact Supplier

Contact Supplier

Related Companies

Related Companies

Alnylam is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of patients who have limited or inadequate treatment options. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of debilitating diseases with high unmet medical need. Alnylam marked by it...

Alnylam is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of patients who have limited or inadequate treatment options. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of debilitating diseases with high unmet medical need. Alnylam marked by its robust discovery platform and deep pipeline of investigational medicines, including 4 programs in late-stage clinical development.

Sponsored Ad

seqens-m-2022-11-21

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

seqens-m-2022-11-21

Access Virtual Booth

Contact Supplier

Send me more info on How To Grow My Business Digitally?

Market Place

Home

Menu

Post Enquiry

Market Place

Search